02196.HK
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 16.20
+0.37%Forward multiples
Based on analyst estimates
- P/E forward
- 20.58x
- P/E 2026E
- 9.31x
- P/E 2027E
- 8.32x
- P/E 2028E
- 7.33x
- P/S forward
- 1.99x
Trailing multiples
Trailing twelve months
- P/E TTM
- 7.31x
- PEG TTM
- —
- Price / book
- 0.75x
- Price / sales
- 0.59x
- Price / cash flow
- 6.66x
Enterprise value
- Enterprise value
- HKD 86.9B
- EV / sales
- 1.21x
- EV / EBITDA
- 10.05x
- EV / EBIT
- 14.53x
- Market cap
- HKD 42.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026